18.6 million Americans who have finished active cancer treatment are stuck in a gap between 'done with chemo' and 'back to normal.' They face chemo brain, body changes, crushing medical debt, fear of recurrence, and a lost sense of identity — with almost no structured support from the healthcare system once treatment ends.
18.6 million U.S. cancer survivors as of 2025 will grow to 22 million+ by 2035, meaning the addressable post-treatment audience expands by roughly 350,000 new survivors each year — a steady inflow of first-time buyers entering the rebuilding phase (American Cancer Society / City of Hope, June 2026).
Only about 1 in 3 survivors who finished treatment 5+ years ago are receiving any survivorship care, and 58% were told by their doctor it was no longer needed — a documented care cliff that creates an underserved market hungry for non-clinical guidance (Knowable Magazine / 2025 patient survey, April 2026).
The cancer rehabilitation services market is valued at $1.26 billion in 2026 and growing at 8% CAGR through 2035 — institutional money is flowing in, which validates the commercial demand and signals that digital, direct-to-consumer players can ride the same tailwind (Business Research Insights, 2026).
The exact words they type into Google.
Create a free account to unlock the full breakdown — all 3 ideas and every community map on the site.
Free forever. No credit card. Takes 20 seconds.